June 2012 - Class Action Blog Archive
A new Canadian study shows that taking the diabetes drug Actos for two years could double a patient’s risk for bladder cancer.
An online petition has been created to highlight the widespread problems surrounding the intrauterine device (IUD) Mirena and has already signed by almost 1,500 women.
Facebook, the behemoth social media corporation that had its initial public offering (IPO) in May, is the target of several class-action lawsuits spanning multiple alleged violations.
An advisory committee of the U.S. Food and Drug Administration (FDA) is set to discuss the risks and benefits of metal-on-metal hip replacements at a two-day meeting on June 27-28, 2012.
Johnson & Johnson has earmarked $600 million to cover a possible settlement of lawsuits claiming that it paid kickbacks to Omnicare to buy more of certain drugs.
Chrysler has announced that it is expanding its recall of Jeep Liberty SUVs for possible corrosion issues that could cause crashes.
A motion has been filed before the Judicial Panel on Multidistrict Litigation requesting for consolidation of all pending and future product liability lawsuits against Pradaxa into an MDL docket.
Johnson & Johnson and its subsidiary Ethicon have told a judge in West Virginia that they will cease marketing, production, and sales of four problematic transvaginal mesh implants.